Injective (INJ) is currently priced at $2.96, with a slight 24-hour change of -0.03706%. The daily range has been relatively narrow, fluctuating between a high of $2.98 and a low of $2.87, indicating a stable price environment.

The trading volume stands at 39,456,802, accounting for 13.30% of the market cap, which is significant for assessing liquidity. The hourly moving averages reveal bullish momentum, with the 8 SMA, 13 SMA, and 21 SMA all above $2.90, indicating a potential upward trend.

The 1-hour RSI is at 63, suggesting that INJ is approaching overbought territory but still has room for further gains. Meanwhile, the 7-day RSI is at 55, reflecting a neutral position with recent price performance showing a 6.85% increase over the past week, which is encouraging.

Over a longer time frame, the 14-day price change is marginally positive at 0.35%, while the 30-day change shows a decline of -1.59%. This indicates some volatility in the past month, but the recent uptrend over the last week could suggest a potential recovery phase.

The all-time high for INJ remains at $52.62, reached in March 2024, indicating significant potential for future price appreciation. Given the current price levels and the indicators pointing towards bullish momentum, there may be favorable conditions for short-term trading.

Based on the current analysis, I assign a Buy rating for INJ. The combination of positive short-term indicators and stable market behavior suggests that the price could rise in the near future, making it an opportune time for entry.